Cotinga Pharmaceuticals (COT) Reaches New 52-Week Low at $0.07

Cotinga Pharmaceuticals Inc (CVE:COT)’s share price hit a new 52-week low on Tuesday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 48725 shares trading hands. The stock had previously closed at C$0.07.

Cotinga Pharmaceuticals (CVE:COT) last announced its quarterly earnings results on Tuesday, August 28th. The company reported C($0.10) earnings per share for the quarter.

About Cotinga Pharmaceuticals (CVE:COT)

Cotinga Pharmaceuticals Inc, a biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, a clinical stage oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions.

Featured Story: Momentum Indicator: Relative Strength Index

Receive News & Ratings for Cotinga Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotinga Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply